The Importance of Heparan Sulfate in Herpesvirus Infection
- Received Date: 08 August 2008
- Accepted Date: 27 August 2008
Abstract: Heparan sulfate (HS); Herpesviruses; Herpes simplex virus type-1 (HSV-1); 3-O-sulfotransferases; Viral entry
Akula S M, Wang F Z, Vierira J, et al. 2001. Human herpesvirus 8 (HHV8/KSHV) infection of target cells involves interaction with heparan sulfate. Virology, 282 (2): 245-255.
doi: 10.1006/viro.2000.0851
Andersen J H, Jenssen H, Gutteberg T J. 2003. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res, 58 (3): 209-215.
doi: 10.1016/S0166-3542(02)00214-0
Andersen, J H, Jenssen H, Sandvik K, et al. 2004. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J Med Virol, 74 (2): 262-271.
doi: 10.1002/(ISSN)1096-9071
Bacon T H, Levin M J, Leary J L, et al. 2003. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev, 16 (1): 114-128.
doi: 10.1128/CMR.16.1.114-128.2003
Barth H, Schafer C, Adah M I, et al. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem, 278 (42): 41003-41012.
doi: 10.1074/jbc.M302267200
Brady R C, Bernstein D I. 2004. Treatment of herpes simplex virus infections. Antiviral Res, 61(2): 73–81.
doi: 10.1016/j.antiviral.2003.09.006
Campadelli-Fiume G, Cocchi F, Menotti L, et al. 2000. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol, 10 (5): 305-319.
doi: 10.1002/(ISSN)1099-1654
Carfi A, Willis S H, Whitbeck J C, et al. 2001. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell, 8 (1): 169-179.
doi: 10.1016/S1097-2765(01)00298-2
Chen J, Avci F Y, Munoz E M, et al. 2005. Enzymatically redesigning of biologically active heparan sulfate. J Biol Chem, 280 (52): 42817-42825.
doi: 10.1074/jbc.M504338200
Chen Y, Maguire T, Hileman R E, et al. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3 (8): 866-871
doi: 10.1038/nm0897-866
Clement C, Tiwari V, Scanlan P M, et al. 2006. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol, 174 (7): 1009-1021.
doi: 10.1083/jcb.200509155
Compton T, Nowlin D M, Cooper N R. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193 (2): 834-841.
doi: 10.1006/viro.1993.1192
Copeland R, Balasubramaniam A, Tiwari V, et al. 2008. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry, 47 (21): 5774-5783.
doi: 10.1021/bi800205t
Corey L, Spear P G. 1986. Infections with herpes simplex viruses.N Engl J Med, 314 (11): 686-691.
doi: 10.1056/NEJM198603133141105
Dyer A P, Banfield B W, Martindale D, et al. 1997. Dextran sulfate can act as an artificial receptor to mediate a typespecific herpes simplex virus infection via glyco-protein B. J Virol, 71(1): 191-198.
Eizuru Y. 2003. Development of new antivirals for herpes-viruses. Antivir Chem Chemother, 14 (6): 299-308.
doi: 10.1177/095632020301400602
Esko J D, Lindahl U. 2001. Molecular diversity of heparan sulfate.J Clin Invest, 108 (2): 169-173.
doi: 10.1172/JCI200113530
Feyzi E, Trybala E, Bergstrom T, et al. 1997. Structural requirement of heparan sulphate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem, 272 (40): 24850-24857.
doi: 10.1074/jbc.272.40.24850
Friedman H M, Cohen G H, Eisenberg R J, et al. 1984. Glycoprotein C of herpes simplex virus type 1 acts as a receptor for C3b component of complement on infected cells. Nature, 309(5969): 633-635.
doi: 10.1038/309633a0
Geraghty R J, Krummenacher C, Cohen G H, et al. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science, 280 (5369): 1618-1620.
doi: 10.1126/science.280.5369.1618
Hasegawa K, Motsuchi W, Tanaka S, et al. 1994. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol, 47 (2): 73-85.
doi: 10.7883/yoken1952.47.73
Hayashi T, Hayashi K, Maeda M, et al. 1996. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod, 59 (1): 83-87.
doi: 10.1021/np960017o
Herold B C, Gerber S I, Polonsky T, et al. 1995. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology, 206 (2): 1108-1116.
doi: 10.1006/viro.1995.1034
Herold B C, Siston A, Bremer J, et al. 1997. Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob. Agents Chemother, 41 (12): 2776-2780.
Herold B C, Visalli R J, Susmarski N, et al. 1994. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol, 75 (Pt 6): 1211-1222.
Herold B C, WuDunn D, Soltys N, et al. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol, 65 (3): 1090-1098.
Hutton R D, Ewert D L, French G R. 1973. Differentiation of types 1 and 2 of herpes simplex virus by plaque inhibition with sulfated polyanions. Proc Soc Exp Biol Med, 142(1):27-29.
doi: 10.3181/00379727-142-36950
Gerber S I, Belval B J, Herold B C. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.Virology, 214 (1): 29-39.
doi: 10.1006/viro.1995.9957
Giroglou T, Florin L, Schafer F, et al. 2001. Human papillomavirus infection requires cell surface heparan sulfate. J Virol, 75 (3): 1565-1570.
doi: 10.1128/JVI.75.3.1565-1570.2001
Gruenheid S, Gatzke L, Meadows H, et al. 1993. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol, 67 (1): 93-100.
Jacquet A, Haumont M, Chellun D, et al. 1998. The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans. Virus Res, 53 (2): 197-207.
doi: 10.1016/S0168-1702(97)00149-4
Jenssen H. 2005. Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell Mol Life Sci, 62 (24): 3002-3013.
doi: 10.1007/s00018-005-5228-7
Jenssen H, Andersen J H, Mantzilas D, et al. 2004. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antiviral Res, 64 (2): 119-126.
doi: 10.1016/S0166-3542(04)00166-4
Jenssen H, Andersen J H, Uhlin-Hansen L, et al. 2004. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res, 61 (2): 101-109.
doi: 10.1016/j.antiviral.2003.09.001
Jenssen H, Hamill P, Hancock R E. 2006. Peptide antimicrobial agents. Clin Microbiol Rev, 19(3): 491–511.
doi: 10.1128/CMR.00056-05
Jenssen H, Sandvik K, Andersen J H, et al. 2008. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin. Antiviral Res, 79 (3): 192-198.
doi: 10.1016/j.antiviral.2008.03.004
Inatani M, Irie F, Plump A S, et al. 2003. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science, 302(5647): 1044–1046.
doi: 10.1126/science.1090497
Kwon H, Bai Q, Baek H J, et al. 2006. Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. J Virol, 80 (1): 138-148.
doi: 10.1128/JVI.80.1.138-148.2006
Langeland N, Holmsen H, Lillehaug J R, et al. 1987. Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J Virol, 61 (11): 3388-3393.
Langeland N, Moore L J, Holmsen H, et al. 1998. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J Gen Virol, 69 (Pt 6): 1137-1145.
Laquerre S, Argnani R, Anderson D B, et al. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol, 72 (7): 6119-6130.
Lee J B, Hayashi K, Hashimoto M, et al. 2004. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu).Chem Pharm Bull (Tokyo), 52 (9): 1091-1094.
doi: 10.1248/cpb.52.1091
Legrand D, Pierce A, Elass E, et al. 2008. Lactoferrin structure and functions. Adv Exp Med Biol, 606: 163-194.
doi: 10.1007/978-0-387-74087-4
Liang X, Babiuk L A, Zamb T J. 1993. Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins. Virology, 194 (1): 233-243.
doi: 10.1006/viro.1993.1254
Lindahl U, Kusche-Gullberg M, Kjellén L. 1998. Regulated diversity of heparan sulfate. J Biol Chem, 273 (39): 24979-24982.
doi: 10.1074/jbc.273.39.24979
Liu J, Shriver Z, Pope R M, et al. 2002. Characterization of a heparan sulphate octasaccharide that binds to herpes simplex viral type 1 glycoprotein D. J Biol Chem, 277 (36): 33456-33467.
doi: 10.1074/jbc.M202034200
Liu J, Shworak N W, Sinay P, et al. 1999. Expression of heparan sulphate D glucosaminyl 3-O sulphotransferase isoforms reveals novel substrate specificities. J Biol Chem, 274 (8): 5185-5192.
doi: 10.1074/jbc.274.8.5185
Lycke E, Johansson M, Svennerholm B, et al. 1991. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol, 72 (Pt 5): 1131-1137.
Marchetti M, Longhi C, Conte M P, et al. 1996. Lactoferrin inhibits herpes simplex virus type1 adsorption to Vero cells. Antiviral Res, 29 (2-3): 221-231.
doi: 10.1016/0166-3542(95)00840-3
Marchetti M, Pisani S, Antonini G, et al. 1998. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. Biometals, 11 (2):89-94.
doi: 10.1023/A:1009217709851
Mardberg K, Trybala E, Glorioso J C, et al. 2001. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J Gen Virol, 82 (Pt 8): 1941-1950.
McKeehan W L, Wu X, Kan M. 1999. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J Biol Chem, 274 (31): 21511-21514.
doi: 10.1074/jbc.274.31.21511
Montgomery R I, Warner M S, Lum B J, et al. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell, 87 (3): 427-436.
doi: 10.1016/S0092-8674(00)81363-X
Nahmias A J, Kibrick S. 1964. Inhibitory effect of heparin on herpes simplex virus. J Bacteriol, 87 (5): 1060-1066.
Neyts J, Snoeck R, Schols D, et al. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology, 189 (1): 48-58.
doi: 10.1016/0042-6822(92)90680-N
Nicola A V, McEvoy A M, Straus S E. 2003. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol, 77 (9): 5324-5332.
doi: 10.1128/JVI.77.9.5324-5332.2003
Nyberg K, Ekblad M, Bergstrom T, et al.2004. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res, 63 (1): 15-24.
doi: 10.1016/j.antiviral.2004.01.001
O'Donnell C D, Tiwari V, Oh M J, et al. 2006. A role for heparan sulfate 3-O sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology, 346 (2): 452-459.
doi: 10.1016/j.virol.2005.11.003
Pertel P E, Fridberg A, Parish M L, et al. 2001. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology, 279 (1): 313-324.
doi: 10.1006/viro.2000.0713
Ponce N M, Pujol C A, Damonte E B, et al. 2003. Fucoidans from the brown seaweed Adenocystis utricularis: extraction methods, antiviral activity and structural studies. Carbohydr Res, 338 (2): 153-165.
doi: 10.1016/S0008-6215(02)00403-2
Preeprame S, Hayashi K, Lee J, et al. 2001. A novel antivirally active fucan sulfate derived from an edible brown alga, Sargassum horneri. Chem Pharm Bull (Tokyo), 49 (4): 484-485.
doi: 10.1248/cpb.49.484
Raghuraman A, Tiwari V, Zhao Q, et al. 2007. Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules, 8 (5): 1759-1763.
doi: 10.1021/bm0701651
Rosenberg R D, Shworak N W, Liu J, et al. 1997. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest, 99 (9): 2062-2070.
Scanlan P M, Tiwari V, Bommireddy S, et al. 2005. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion. J Virol Methods, 128 (1-2): 104-112.
doi: 10.1016/j.jviromet.2005.04.008
Shieh M T, WuDunn D, Montgomery R I, et al. 1992. Cell surface receptors for herpes simplex virus are heparan sulphate proteoglycans. J Cell Biol, 116 (5): 1273-1281.
doi: 10.1083/jcb.116.5.1273
Shukla D, Liu J, Blaiklock P, et al. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell, 99 (1): 13-22.
doi: 10.1016/S0092-8674(00)80058-6
Shukla D, Spear P G. 2001. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest, 108 (4): 503-510.
doi: 10.1172/JCI200113799
Shworak N W, Liu J, Petros L M, et al. 1999. Multiple isoforms of heparan sulfate D glucosaminyl 3-O-sulfotrans-ferase. Isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci. J Biol Chem, 274 (8): 5170-5184.
doi: 10.1074/jbc.274.8.5170
Shworak N W, HajMohammadi S, de Agostini A I, et al. 2002. Mice deficient in heparan sulfate 3-O-sulfotrans-ferase-1: normal hemostasis with unexpected perinatal phenotypes. Glycoconj J, 19(4-5): 355-361.
Skrincosky D, Hocknell P, Whetter L, et al. 2000. Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7. J Virol, 74 (10): 4530-4540.
doi: 10.1128/JVI.74.10.4530-4540.2000
Spear P G, Longnecker R. 2003. Herpesvirus entry: an update.J Virol, 77 (19): 10179-10185.
doi: 10.1128/JVI.77.19.10179-10185.2003
Spear P G, Shieh M T, Herold B C, et al. 1992. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol, 313: 341-353.
doi: 10.1007/978-1-4899-2444-5
Svennerholm B, Jeansson S, Vahlne A, et al. 1991.Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell. Arch Virol, 120 (3-4): 273-279.
doi: 10.1007/BF01310482
Tal-Singer R, Peng C, Ponce De Leon M, et al. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol, 69 (7): 4471-4483.
Tiwari V, Clement C, Duncan M B, et al. 2004. A role for 3-O-sulphated heparan sulphate in cell fusion induced by herpes simplex virus type 1. J Gen Virol, 85 (Pt 4): 805-809.
Tiwari V, O'Donnell C D, Oh M J, et al. 2005. A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochem Biophys Res Commun, 338 (2): 930-937.
doi: 10.1016/j.bbrc.2005.10.056
Tiwari V, O'Donnell, C, Copeland R J, et al. 2007. Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells. J Gen Virol, 88:1075-1079.
doi: 10.1099/vir.0.82476-0
Tiwari V, ten Dam G B, Yue B Y, et al.2007. Role of 3-O-sulfated heparan sulfate in virus-induced polykary-ocyte formation. FEBS Lett, 581 (23): 4468-4472.
doi: 10.1016/j.febslet.2007.08.029
Trybala E, Bergstrom T, Svennerholm B, et al. 1994. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol, 75 (Pt 4): 743-752.
Trybala E, Bergstrom T, Spillmann D, et al. 1998. Interaction between pseudorabies virus and heparin/ heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain. J Biol Chem, 273 (9): 5047-5052.
doi: 10.1074/jbc.273.9.5047
Trybala E, Liljeqvist J A, Svennerholm B, et al. 2000. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol, 74 (19): 9106-9114.
doi: 10.1128/JVI.74.19.9106-9114.2000
Trybala E, Olofsson S, Mardberg K, et al. 2004. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Res, 62 (3): 125-134.
doi: 10.1016/j.antiviral.2003.12.007
Tyagi M, Rusnati M, Presta M, et al. 2001. Internali-zation of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J Biol Chem, 276 (5): 3254-3261.
doi: 10.1074/jbc.M006701200
Vanderplasschen A, Bublot, M, Dubuisson J, et al. 1993. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface. Virology, 196 (1): 232-240.
doi: 10.1006/viro.1993.1471
Wang F Z, Akula S M, Pramod N P, et al. 2001. Human herpesvirus 8 envelope glycoprotein K8.1 A interaction with the target cells involves heparan sulfate. J Virol, 75 (16): 7517-7527.
doi: 10.1128/JVI.75.16.7517-7527.2001
WuDunn D, Spear P G. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulphate. J Virol, 63 (1): 52-58.
Xia G, Chen J, Tiwari V, et al. 2002. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an anti-thrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem, 277 (40): 37912-37919.
doi: 10.1074/jbc.M204209200
Xu D, Moon A, Song D, et al. 2008. Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol, 4 (3): 200-202.
doi: 10.1038/nchembio.66
Xu D, Tiwari V, Xia G, et al. 2005. Characterization of heparan sulphate 3-O sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. Biochem J, 385 (Pt 2): 451-459.
Yabe T, Shukla D, Spear P G, et al. 2001. Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases. Biochem J, 359 (Pt 1): 235-241.
Yamaguchi Y. 2001. Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin Cell Dev Biol, 12: 99-106.
doi: 10.1006/scdb.2000.0238
Yoon M, Zago A, Shukla D, et al. 2003. Mutations in the N-termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, Nectin-2, and 3-O-sulphated heparan sulphate but not with Nectin-1. J Virol, 77 (17): 9221-9231.
doi: 10.1128/JVI.77.17.9221-9231.2003
Abstract: Heparan sulfate (HS); Herpesviruses; Herpes simplex virus type-1 (HSV-1); 3-O-sulfotransferases; Viral entry